Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $2550.0000 (0%) ($0.0000 - $0.0000) on Mon. Dec. 8, 2003. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 8.25% (three month average) | RSI | 0 | Latest Price | $2550.0000(0%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 33.3% a day on average for past five trading days. | Weekly Trend | CAPR declines -8.1% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) EWJ(2%) EWP(2%) EWI(1%) IWM(1%) QQQ(1%) | Factors Impacting CAPR price | CAPR will decline at least -4.125% in a week (0% probabilities). XLY(0%) XLU(-0%) XLP(0%) XLK(0%) TLT(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -4.125% (StdDev 8.25%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
Resistance Level | $3019.39 | 5 Day Moving Average | $2040(25%) | 10 Day Moving Average | $2894.18(-11.89%) | 20 Day Moving Average | $3019.39(-15.55%) | To recent high | 0% | To recent low | 0% | Market Cap | $50.229b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |